Literature DB >> 14758550

In situ expression of connective tissue growth factor in human crescentic glomerulonephritis.

Katsuyoshi Kanemoto1, Joichi Usui, Kosaku Nitta, Shigeru Horita, Atsumi Harada, Akio Koyama, Jan Aten, Michio Nagata.   

Abstract

Connective tissue growth factor (CTGF) has recently been recognized as an important profibrotic factor and is up-regulated in various renal diseases with fibrosis. The present study describes the sequential localization of CTGF mRNA and its association with transforming growth factor (TGF)-beta1 in human crescentic glomerulonephritis (CRGN). Furthermore, we examined the phenotype of CTGF-expressing cells using serial section analysis. Kidney biopsy specimens from 18 CRGN patients were examined using in situ hybridization and immunohistochemistry. CTGF mRNA was expressed in the podocytes and parietal epithelial cells (PECs) in unaffected glomeruli. In addition, it was strongly expressed in the cellular and fibrocellular crescents, particularly in pseudotubule structures. Serial sections revealed that the majority of CTGF mRNA-positive cells in the crescents co-expressed the epithelial marker cytokeratin, but not a marker for macrophages. Moreover, TGF-beta1, its receptor TGF-beta receptor-I, and extracellular matrix molecules (collagen type I and fibronectin) were co-localized with CTGF mRNA-positive crescents. Our results suggest that CTGF is involved in extracellular matrix production in PECs and that it is one of the mediators promoting the scarring process in glomerular crescents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14758550     DOI: 10.1007/s00428-003-0959-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  33 in total

1.  Histogenesis of glomerular crescents. Immunohistochemical demonstration of cytokeratin in crescent cells.

Authors:  A B Magil
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

Review 2.  The modular architecture of a new family of growth regulators related to connective tissue growth factor.

Authors:  P Bork
Journal:  FEBS Lett       Date:  1993-07-26       Impact factor: 4.124

3.  The epithelial antigen phenotype of glomerular crescent cells.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Clin Pathol       Date:  1986-09       Impact factor: 2.493

4.  In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury.

Authors:  I E Blom; A J van Dijk; L Wieten; K Duran; Y Ito; L Kleij; M deNichilo; T J Rabelink; J J Weening; J Aten; R Goldschmeding
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

5.  Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP.

Authors:  Juliane Heusinger-Ribeiro; Michael Eberlein; Nadia Abdel Wahab; Margarete Goppelt-Struebe
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

6.  Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis.

Authors:  Yasuhiko Ito; Roel Goldschmeding; Richard J Bende; Nike Claessen; M Anwar Chand; Livio Kleij; Ton J Rabelink; Jan J Weening; Jan Aten
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

7.  CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.

Authors:  Youjun Chen; Ingrid E Blom; Susan Sa; Roel Goldschmeding; David J Abraham; Andrew Leask
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

8.  Studies on "end-stage" kidneys. II. Embryonal hyperplasia of Bowman's capsular epithelium.

Authors:  M D Hughson; J F McManus; G R Hennigar
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

9.  Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis.

Authors:  Katsuyoshi Kanemoto; Joichi Usui; Shinsuke Tomari; Hideki Yokoi; Masashi Mukoyama; Jan Aten; Jan J Weening; Michio Nagata
Journal:  Lab Invest       Date:  2003-11       Impact factor: 5.662

10.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.

Authors:  D M Bradham; A Igarashi; R L Potter; G R Grotendorst
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

View more
  11 in total

Review 1.  The enigmatic parietal epithelial cell is finally getting noticed: a review.

Authors:  Takamoto Ohse; Jeffrey W Pippin; Alice M Chang; Ronald D Krofft; Jeffrey H Miner; Michael R Vaughan; Stuart J Shankland
Journal:  Kidney Int       Date:  2009-10-21       Impact factor: 10.612

2.  Connective Tissue Growth Factor Domain 4 Amplifies Fibrotic Kidney Disease through Activation of LDL Receptor-Related Protein 6.

Authors:  Bryce G Johnson; Shuyu Ren; Gamze Karaca; Ivan G Gomez; Cécile Fligny; Benjamin Smith; Ayla Ergun; George Locke; Benbo Gao; Sebastian Hayes; Scott MacDonnell; Jeremy S Duffield
Journal:  J Am Soc Nephrol       Date:  2017-01-27       Impact factor: 10.121

3.  Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.

Authors:  Maartje C J Slagman; Tri Q Nguyen; Femke Waanders; Liffert Vogt; Marc H Hemmelder; Gozewijn D Laverman; Roel Goldschmeding; Gerjan Navis
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

Review 4.  Therapeutic targets for treating fibrotic kidney diseases.

Authors:  So-Young Lee; Sung I Kim; Mary E Choi
Journal:  Transl Res       Date:  2014-08-13       Impact factor: 7.012

5.  Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis.

Authors:  Bart Smeets; Maria Lucia Angelotti; Paola Rizzo; Henry Dijkman; Elena Lazzeri; Fieke Mooren; Lara Ballerini; Eliana Parente; Costanza Sagrinati; Benedetta Mazzinghi; Elisa Ronconi; Francesca Becherucci; Ariela Benigni; Eric Steenbergen; Laura Lasagni; Giuseppe Remuzzi; Jack Wetzels; Paola Romagnani
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

6.  Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.

Authors:  Roger M Mason
Journal:  Int J Exp Pathol       Date:  2012-10-30       Impact factor: 1.925

Review 7.  Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?

Authors:  Tri Q Nguyen; Roel Goldschmeding
Journal:  Pharm Res       Date:  2008-02-12       Impact factor: 4.200

8.  Urinary podocyte and TGF-β1 mRNA as markers for disease activity and progression in anti-glomerular basement membrane nephritis.

Authors:  Akihiro Fukuda; Akihiro Minakawa; Yuji Sato; Takashi Iwakiri; Shuji Iwatsubo; Hiroyuki Komatsu; Masao Kikuchi; Kazuo Kitamura; Roger C Wiggins; Shouichi Fujimoto
Journal:  Nephrol Dial Transplant       Date:  2017-11-01       Impact factor: 5.992

9.  Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis.

Authors:  Dimitrios S Goumenos; Pantelitsa Kalliakmani; Sotiris Tsakas; Florentia Sotsiou; John G Vlachojannis
Journal:  BMC Nephrol       Date:  2005-12-20       Impact factor: 2.388

Review 10.  Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.

Authors:  Hiroshi Kinashi; Yasuhiko Ito; Ting Sun; Takayuki Katsuno; Yoshifumi Takei
Journal:  Int J Mol Sci       Date:  2018-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.